Company Performance Metrics
NK Bioscience is a biotechnology company developing engineered natural killer cell immunotherapies for solid tumors. The company focuses on creating NK cell lines that grow, proliferate, and retain cytotoxic activity in highly immunosuppressive tumor microenvironments. Its research platform produces human NK cells that survive and function in the
presence of major immunosuppressive factors and continue to kill metastatic tumor cells. NK Bioscience advances a pipeline of NK cell therapy candidates intended for use in oncology, with plans to move lead products into preclinical testing and early phase clinical trials. The company also works to secure intellectual property around its proprietary cell lines and to support future regulatory submissions and partnering activities.
